Announced Tue, 30 Sept · 23:25 IST

Change in designation of Dr. Avinash Yaramati from Additional Director to Director of the Company

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

B2B Software Technologies Ltd (BSE Scrip Code: 531268) informed the stock exchange that the members of the company approved the regularization of Dr. Avinash Yaramati (DIN: 09804102) as a Non-Executive Director at the 31st Annual General Meeting held on 29th September 2025 through video conferencing. Dr. Avinash was originally appointed as an Additional Director (Non-Executive category) on 12th July 2025 and has now been formally confirmed as a Director, liable to retire by rotation. He holds an M.S. in General Surgery and an M.B.B.S., with clinical experience at Star Hospitals, Hyderabad and academic roles at NIMS and other institutions.

Likely market impact

This is a routine corporate governance step where a director, initially appointed in an additional capacity, gets confirmed by shareholders. It is unlikely to have a material impact on the stock price or shareholder value.